Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Jane Street Group LLC

Jane Street Group LLC cut its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 27.0% in the third quarter, Holdings Channel.com reports. The fund owned 21,624 shares of the company’s stock after selling 8,001 shares during the period. Jane Street Group LLC’s holdings in Henry Schein were worth $1,576,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in HSIC. Cromwell Holdings LLC increased its holdings in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares during the last quarter. Farther Finance Advisors LLC grew its stake in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after buying an additional 346 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its holdings in shares of Henry Schein by 282.1% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after buying an additional 1,100 shares during the period. Huntington National Bank raised its holdings in shares of Henry Schein by 16.8% in the 3rd quarter. Huntington National Bank now owns 1,515 shares of the company’s stock valued at $110,000 after buying an additional 218 shares during the period. Finally, Atlas Capital Advisors LLC acquired a new position in Henry Schein during the 2nd quarter worth about $128,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Stock Up 1.4 %

HSIC opened at $70.97 on Friday. The firm has a market cap of $8.85 billion, a P/E ratio of 29.21, a PEG ratio of 2.31 and a beta of 0.87. The business’s fifty day simple moving average is $72.32 and its 200 day simple moving average is $70.15. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s revenue was up .4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.32 EPS. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Analysts Set New Price Targets

HSIC has been the topic of several research reports. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Mizuho initiated coverage on shares of Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. Evercore ISI boosted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Finally, Barrington Research reiterated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a research note on Wednesday, November 6th. Seven research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $78.89.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.